Summary ready · Free
Two primary cancers: which should be treated first, and how should treatment be combined?
Two primary cancers: which should be treated first, and how should treatment be combined?
Materials sorted into two groups: confirmed, needs verification
Ready to share with a doctorConfirmed facts
Supported by materials · 12- Patient basicsMale, 59, with a smoking history; denies tuberculosis history and family cancer history
- Laryngeal cancer pathologyModerately–poorly differentiated squamous cell carcinoma of the larynx; IHC CK5/6(+), P40(+), Ki-67 ≈ 60%
- Laryngeal cancer clinical stagecT3N2M0, stage III; tumor confined to the larynx with restricted vocal-cord movement; multiple right cervical lymph-node metastases
- Lung adenocarcinoma diagnosis2.0 × 1.9 cm lesion in the right middle lobe; needle biopsy confirmed lung adenocarcinoma
- Lung cancer genomic testingNGS found no clear driver-gene mutation
- Lung cancer PD-L1 expressionTPS = 10%, low expression
- CT imaging findingsMultiple enlarged right cervical lymph nodes (short axis up to ~1.8 cm), considered regional metastasis from the laryngeal cancer
- Mediastinal lymph nodesEnlarged stations R2 and R4 (short axis up to ~1.6 cm), considered regional metastasis from the lung cancer
- Bilateral hilar node calcificationOld inflammatory change, with no acute significance
- Distant metastasis work-upPET-CT and CT found no pleural effusion, pericardial effusion, chest-wall bone involvement, or other signs of distant metastasis
- Laryngeal biopsy specimenNo clear vascular tumor thrombus or nerve invasion
- Visit statusThe patient consulted in March 2026 but was not present in person; no physical examination on record
Needs verification
Present but needs review · 8- AI-generated content flagBoth reports are marked “parts may be AI-generated”; authenticity needs physician review
- Primary laryngeal site unclearReports do not specify whether the primary is glottic, supraglottic, or subglottic
- Nature of the stagingCurrent stage is pre-treatment clinical (c) staging, not post-surgical pathological staging; the final stage needs the surgical specimen
- No physical examinationThe patient was not present, so there is no actual physical-exam data
- Laryngeal TNM evidence gapNo original imaging or endoscopy description supports “restricted vocal-cord movement”
- Lung cancer N2 not pathologically provenMediastinal node metastasis is based on CT imaging only; no EBUS-TBNA or other pathological confirmation
- Prior anti-tumor treatment unclearWhether the patient has had surgery, radiotherapy, or drug therapy is not documented
- Performance status unknownNo ECOG or KPS score, which affects treatment-plan options
What happened, in time order
From materials you submitted- 2026-03Laryngeal cancer and lung cancer found at another hospital; diagnosed as two primary malignancies
- 2026-03Contrast-enhanced CT of the head, neck, and chest: laryngeal mass with enlarged cervical and mediastinal lymph nodes
- 2026-03PET-CT: ~2 cm lesion in the right middle lobe; enlarged R2 and R4 mediastinal lymph nodes
- 2026-03Needle biopsy of the right-middle-lobe lesion; pathology confirmed lung adenocarcinoma
- 2026-03NGS genomic testing: no clear driver-gene mutation found
- 2026-03PD-L1 testing: TPS = 10%
- 2026-03Laryngeal biopsy: moderately–poorly differentiated squamous cell carcinoma
- 2026-03Laryngeal cancer clinically staged as cT3N2M0, stage III
- 2026-03The patient consulted but was not present in person; no physical examination recorded
Does this need a doctor? Which specialties?
Yes — and no single specialty can answer it alone.
The patient has stage III laryngeal cancer and lung adenocarcinoma with mediastinal lymph-node metastasis at the same time. The decisions span head & neck surgery and thoracic surgery, and the two tumors are independent and each needs its own plan — so a multidisciplinary team must jointly assess treatment priority and the combined strategy.
-
RadiologyJudge from imaging whether the double-primary diagnosis is accurate, and whether metastases elsewhere have been missedDo the imaging features of the laryngeal and lung lesions support two independent primary cancers?; Are there occult distant metastases that CT or PET-CT may have missed?; Do the mediastinal and cervical nodes need further imaging confirmation?
-
Otolaryngology (ENT)Assess the severity of the laryngeal cancer, and decide the surgical approach and the management of cervical lymph nodesWhat is the primary laryngeal site (glottic, supraglottic, or subglottic)?; Which type of surgery is appropriate for the laryngeal tumor?; How should the multiple cervical node metastases be handled?
-
Thoracic surgeryAssess whether the lung adenocarcinoma is resectable, and the extent of resection requiredIs the lung cancer with mediastinal node metastasis still resectable?; If surgery is possible, what needs to be removed?; Do the mediastinal nodes need pathological confirmation before surgery?
-
Medical oncologyChoose the systemic drug therapy for lung adenocarcinoma without a driver mutationWhat is the first-choice drug therapy when there is no driver mutation?; What does low PD-L1 expression (TPS = 10%) mean for immunotherapy?; How should chemotherapy, targeted therapy, and immunotherapy be combined?
-
Radiation oncologyAssess whether the laryngeal cancer is suitable for radiotherapy, design the radiation field, and sequence it with other treatmentsIs stage III laryngeal cancer suitable for radiotherapy alone or combined with surgery?; If radiotherapy is used, how should the field be designed?; How should radiotherapy be sequenced with surgery and other treatments?
This is an evidence framing based on current materials, not a medical order. Key judgments still need clinicians or an MDT.
Next · Claiming is free · pay only if you want more help
You already have enough to let a doctor make a first-round judgment.
Claim this summary to continue
Sign in to bind this case summary to your account. You can then choose the help you need, add materials, and confirm next steps — right here on the website.
Signing in is free — it unlocks the initial leaning and the full evidence analysis for this case at no charge.
One claim only: one preliminary report can be claimed by only one profile owner.
What would you like help with?
Current decision pointTwo primary cancers: which should be treated first, and how should treatment be combined?
Initial leaning
Two primary malignancies confirmed (stage III laryngeal cancer + lung adenocarcinoma with mediastinal lymph-node metastasis). The initial leaning: ENT and thoracic surgery lead the assessment of surgical feasibility, medical oncology joins for the systemic-therapy plan, and radiation oncology evaluates the organ-preservation strategy. The final treatment priority needs a joint expert ruling.